Donghoon Lee


Mr. Lee is currently a head of Bio Investment Center at SK Inc, an investment holding company of SK group.
He is leading SK group’s bio investment globally by serving as a chairman of BOD at SK Biopharm and as a board member at SK Pharmteco.
Formerly, he was a head of global business at Donga ST and CEO of Donga Socio Holdings.
Prior to joining Donga, he practiced as a partner at Samjong KPMG Investment Advisory in Korea.
He has MBA from The Ohio State University and BBA from Seoul National University.